| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| foreskin keratinocyte (neonatal) | granulocyte-macrophage colony-stimulating factor receptor subunit alpha | biotech | NA | drugbank | Skin Ulcer[MeSHID:D012883] Tendon structure[MeSHID:D013710] Ulcer[MeSHID:D014456] Dermis[MeSHID:D020405] Leg Ulcer[MeSHID:D007871] Venous Insufficiency[MeSHID:D014689] Bone Tissue[MeSHID:D001842] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin keratinocyte (neonatal) | epidermal growth factor receptor | biotech | NA | drugbank | Skin Ulcer[MeSHID:D012883] Tendon structure[MeSHID:D013710] Ulcer[MeSHID:D014456] Dermis[MeSHID:D020405] Leg Ulcer[MeSHID:D007871] Venous Insufficiency[MeSHID:D014689] Bone Tissue[MeSHID:D001842] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin keratinocyte (neonatal) | fibroblast growth factor 1 | biotech | NA | drugbank | Skin Ulcer[MeSHID:D012883] Tendon structure[MeSHID:D013710] Ulcer[MeSHID:D014456] Dermis[MeSHID:D020405] Leg Ulcer[MeSHID:D007871] Venous Insufficiency[MeSHID:D014689] Bone Tissue[MeSHID:D001842] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin keratinocyte (neonatal) | fibroblast growth factor receptor 2 | biotech | NA | drugbank | Skin Ulcer[MeSHID:D012883] Tendon structure[MeSHID:D013710] Ulcer[MeSHID:D014456] Dermis[MeSHID:D020405] Leg Ulcer[MeSHID:D007871] Venous Insufficiency[MeSHID:D014689] Bone Tissue[MeSHID:D001842] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin keratinocyte (neonatal) | interferon gamma | biotech | NA | drugbank | Skin Ulcer[MeSHID:D012883] Tendon structure[MeSHID:D013710] Ulcer[MeSHID:D014456] Dermis[MeSHID:D020405] Leg Ulcer[MeSHID:D007871] Venous Insufficiency[MeSHID:D014689] Bone Tissue[MeSHID:D001842] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin keratinocyte (neonatal) | interleukin-1 beta | biotech | NA | drugbank | Skin Ulcer[MeSHID:D012883] Tendon structure[MeSHID:D013710] Ulcer[MeSHID:D014456] Dermis[MeSHID:D020405] Leg Ulcer[MeSHID:D007871] Venous Insufficiency[MeSHID:D014689] Bone Tissue[MeSHID:D001842] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin keratinocyte (neonatal) | interleukin-6 | biotech | NA | drugbank | Skin Ulcer[MeSHID:D012883] Tendon structure[MeSHID:D013710] Ulcer[MeSHID:D014456] Dermis[MeSHID:D020405] Leg Ulcer[MeSHID:D007871] Venous Insufficiency[MeSHID:D014689] Bone Tissue[MeSHID:D001842] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin keratinocyte (neonatal) | platelet-derived growth factor receptor alpha | biotech | NA | drugbank | Skin Ulcer[MeSHID:D012883] Tendon structure[MeSHID:D013710] Ulcer[MeSHID:D014456] Dermis[MeSHID:D020405] Leg Ulcer[MeSHID:D007871] Venous Insufficiency[MeSHID:D014689] Bone Tissue[MeSHID:D001842] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin keratinocyte (neonatal) | transforming growth factor beta-1 | biotech | NA | drugbank | Skin Ulcer[MeSHID:D012883] Tendon structure[MeSHID:D013710] Ulcer[MeSHID:D014456] Dermis[MeSHID:D020405] Leg Ulcer[MeSHID:D007871] Venous Insufficiency[MeSHID:D014689] Bone Tissue[MeSHID:D001842] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin keratinocyte (neonatal) | tgf-beta receptor type-2 | biotech | NA | drugbank | Skin Ulcer[MeSHID:D012883] Tendon structure[MeSHID:D013710] Ulcer[MeSHID:D014456] Dermis[MeSHID:D020405] Leg Ulcer[MeSHID:D007871] Venous Insufficiency[MeSHID:D014689] Bone Tissue[MeSHID:D001842] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin keratinocyte (neonatal) | tumor necrosis factor | biotech | NA | drugbank | Skin Ulcer[MeSHID:D012883] Tendon structure[MeSHID:D013710] Ulcer[MeSHID:D014456] Dermis[MeSHID:D020405] Leg Ulcer[MeSHID:D007871] Venous Insufficiency[MeSHID:D014689] Bone Tissue[MeSHID:D001842] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin keratinocyte (neonatal) | vascular endothelial growth factor a | biotech | NA | drugbank | Skin Ulcer[MeSHID:D012883] Tendon structure[MeSHID:D013710] Ulcer[MeSHID:D014456] Dermis[MeSHID:D020405] Leg Ulcer[MeSHID:D007871] Venous Insufficiency[MeSHID:D014689] Bone Tissue[MeSHID:D001842] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| click here to return to the previous page | ||||||||